Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H13N3O4 |
Molecular Weight | 299.2814 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)COC1=C(\C=N\NC(=O)C2=CC=NC=C2)C=CC=C1
InChI
InChIKey=MDFXJBQEWLCGHP-RQZCQDPDSA-N
InChI=1S/C15H13N3O4/c19-14(20)10-22-13-4-2-1-3-12(13)9-17-18-15(21)11-5-7-16-8-6-11/h1-9H,10H2,(H,18,21)(H,19,20)/b17-9+
Aconiazide, the isonicotinylhydrazone of 2-formylphenoxyacetic acid, has been used in the treatment and prophylaxis of tuberculosis. Aconiazide is a pro-drug of isoniazid which was designed to be less toxic than the parent drug. Aconiazide is hydrolyzed in the body to isoniazid and 2-formylphenoxyacetic acid. 2-Formylphenoxyacetic acid has been shown to bind hydrazine and acetylhydrazine. This binding could explain the lower toxicity of aconiazide and also could provide a reason for postulating its lack of carcinogenicity.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7937278
Subjects received aconiazide tablets 650 mg (containing isoniazid 300 mg)
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
28288
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Aconiazide
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
DTXSID8046292
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
C76467
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
13410-86-1
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
C028354
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
6433573
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
SUB05246MIG
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
8OKQ9NS8MO
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
100000087670
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL1590674
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY | |||
|
1316
Created by
admin on Fri Dec 15 15:31:23 GMT 2023 , Edited by admin on Fri Dec 15 15:31:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY